Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
PAAB Forum Quarterly Review - Q4/2023
-
Happy New Year @Manufacturer @Agency
As we kick off 2024, let's recap a highly active Q4 in 2023 to make sure you didn't miss anything. You'll now find the PAAB Forum Quarterly Review Q4 posted to the PAAB website.
As always, please share your thoughts and comments below.
We're looking forward another year of growth and collaboration.
